Acadia Healthcare Company, Inc. (ACHC) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 16 Buy, 8 Hold, 1 Sell.
The consensus price target is $19.82 (low: $14.00, high: $25.00), representing a downside of 25.4% from the current price $26.56.
Analysts estimate Earnings Per Share (EPS) of $3.38 and revenue of $3.16B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.79 vs est $3.38 (missed -17.4%). 2025: actual $-12.16 vs est $1.95 (missed -723.7%). Analyst accuracy: 31%.
ACHC Stock — 12-Month Price Forecast
$19.82
▼ -25.38% Downside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Acadia Healthcare Company, Inc., the average price target is $19.82, with a high forecast of $25.00, and a low forecast of $14.00.
The average price target represents a -25.38% change from the last price of $26.56.
Highest Price Target
$25.00
Average Price Target
$19.82
Lowest Price Target
$14.00
ACHC Analyst Ratings
Buy
Based on 25 analysts giving stock ratings to Acadia Healthcare Company, Inc. in the past 3 months
EPS Estimates — ACHC
31%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $2.79
vs Est $3.38
▼ 21.1% off
2025
Actual –$12.16
vs Est $1.95
▼ 116.0% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — ACHC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $3.154B
vs Est $3.159B
▼ 0.1% off
2025
Actual $3.313B
vs Est $3.291B
▲ 0.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
